Hematopoiesis News Volume 12.49 | Dec 14 2021

    0
    19







    2021-12-14 | HN 12.49


    Hematopoiesis News by STEMCELL Technologies
    Vol. 12.49 – 14 December, 2021
    TOP STORY

    Conditionally Pathogenic Genetic Variants of a Hematopoietic Disease–Suppressing Enhancer

    Scientists described conditionally pathogenic enhancer motif variants that differentially affected hematopoietic development and regeneration. Despite normal developmental hematopoiesis, regeneration in response to chemotherapy, inflammation, and a therapeutic HSC mobilizer was compromised.
    [Science Advances]

    Full Article
    Request your free copy of the 'Directed Differentiation of Pluripotent Stem Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    Interleukin-7 Receptor α Mutational Activation Can Initiate Precursor B Cell Acute Lymphoblastic Leukemia

    The authors demonstrated that lymphoid-restricted mutant IL7R, expressed at physiological levels in conditional knock-in mice, established a pre-leukemic stage in which B cell precursors displayed self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-acute lymphoblastic leukemia.
    [Nature Communications]

    Full ArticlePress Release

    Free Fatty-Acid Transport via CD36 Drives β-Oxidation-Mediated Hematopoietic Stem Cell Response to Infection

    Investigators showed that inducible CD36 was required for free fatty acid uptake by HSCs during acute infection, allowing the metabolic transition from glycolysis towards β-oxidation.
    [Nature Communications]

    Full Article

    Gab2 Deficiency Prevents Flt3-ITD Driven Acute Myeloid Leukemia In Vivo

    Utilizing a Flt3-ITD knock-in, Dnmt3a haploinsufficient mouse model, researchers demonstrated that Gab2 was essential for the development of Flt3-ITD driven acute myeloid leukemia in vivo, as Gab2 deficient mice displayed prolonged survival.
    [Leukemia]

    Full Article

    The Onset of Circulation Triggers a Metabolic Switch Required for Endothelial to Hematopoietic Transition

    Investigators showed that in Ncx1/ mouse embryos devoid of circulation, the HSC lineage developed until the phenotypic pro-HSC stage. Experimental activation of glycolysis resulted in decreased intraembryonic hematopoiesis.
    [Cell Reports]

    Full ArticleGraphical Abstract

    CD244 Expression Represents Functional Decline of Murine Hematopoietic Stem Cells after In Vitro Culture

    The authors showed that cultured HSCs expressed mast cell-related genes including Cd244 and suggested CD244 was a potent marker to exclude non-functional HSCs after in vitro culture thereby useful to elucidate mechanism of functional decline of HSCs during ex vivo treatment.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Potent but Transient Immunosuppression of T Cells Is a General Feature of CD71+ Erythroid Cells

    Researchers showed that in mice early-stage CD71+ erythroid cells expanded in anemia, had high levels of arginase 2 and reactive oxygen species.
    [Communications Biology]

    Full Article

    The Distinct Effects of P18 Overexpression on Different Stages of Hematopoiesis Involve TGF-β and Nf-κB Signaling

    The authors established inducible P18/hESC lines and monitored the effects of P18 overexpression on hematopoietic differentiation and found evidence that P18 promoted hematopoiesis, a rare property among cyclin-dependent kinase inhibitors.
    [Scientific Reports]

    Full Article

    Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

    Scientists investigated the recommended dose for expansion of siremadlin, a p53-MDM2 inhibitor, in patients with wild-type TP53 advanced solid or hematologic cancers.
    [Clinical Cancer Research]

    AbstractFull Article

    Impact of Hydroxyurea on Lymphocyte Subsets in Children with Sickle Cell Anemia

    Investigators evaluated the effect of HU on immune profiles through a controlled prospective cohort study conducted in 30 children with sickle cell anemia and 30 healthy age-matched controls.
    [Pediatric Research]

    Abstract
    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    REVIEWS

    Extracorporeal Membrane Oxygenation in Children Receiving Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: An International and Multidisciplinary Consensus Statement

    The authors provide a clinical decision support tool for pediatric hematologists, oncologists, and critical care physicians during the difficult decision-making process of extracorporeal membrane oxygenation candidacy and management.
    [Lancet Child & Adolescent Health]

    Abstract

    High Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Advanced Germ Cell Tumors: State of the Art and a Single-Center Experience

    Scientists review relevant literature, considering endpoints of both survival and long term quality of life and retrospectively evaluate patients with metastatic germ cell tumor progressing after first-line treatment.
    [Critical Reviews in Oncology Hematology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Mustang Bio Announces Updated Interim Phase I/II Data for MB-106 in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Mustang Bio, Inc. announced updated data from the ongoing Phase I/II clinical trial of MB-106, a CD20-targeted, autologous CAR T cell therapy for patients with relapsed or refractory B cell non-Hodgkin lymphomas and chronic lymphocytic leukemia.
    [Mustang Bio, Inc.]

    Press Release
    FEATURED EVENT

    Gene Regulation: From Emerging Technologies to New Models

    January 23 – 26, 2022
    Santa Fe, New Mexico, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – CAR T Cells Engineered to Treat Multiple Myeloma

    Memorial Sloan Kettering – New York City, New York, United States

    Clinical Research Manager – Leukemia Clinical Trials

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Fellowship – Hematopoiesis and Leukemia

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Research Technician – Hematologic Disorders

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Research Fellow – Hematologic Malignancies

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter